Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nicoletta F. Jaberg-Bentele"'
Publikováno v:
Case Reports in Dermatology, Vol 9, Iss 1, Pp 65-68 (2017)
A 47-year-old female patient with rheumatoid arthritis (RA) treated with methotrexate, was diagnosed with metastatic melanoma. After surgical removal of the tumor, the patient started treatment with ipilimumab while methotrexate was stopped. One week
Externí odkaz:
https://doaj.org/article/c7ec067e73b04ea7b672845a33ea43fe
Autor:
Mitchell P. Levesque, Reinhard Dummer, John B.A.G. Haanen, Nicolas Pasqual, Pia Kvistborg, Marieke I.G. Raaijmakers, Thi Dan Linh Nguyen-Kim, Jean-François Mouret, Nadia Plantier, Solène Perez, Manuarii Manuel, Simone M. Goldinger, Nicoletta F. Jaberg-Bentele, Phil F. Cheng, Anaïs Courtier, Sabrina A. Hogan
Effect of previous treatment on variables tested in our model. (Kruskal-Wallis test)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71178e5a80d611fbb75de15696c89e9b
https://doi.org/10.1158/2326-6066.22536035
https://doi.org/10.1158/2326-6066.22536035
Autor:
Mitchell P. Levesque, Reinhard Dummer, John B.A.G. Haanen, Nicolas Pasqual, Pia Kvistborg, Marieke I.G. Raaijmakers, Thi Dan Linh Nguyen-Kim, Jean-François Mouret, Nadia Plantier, Solène Perez, Manuarii Manuel, Simone M. Goldinger, Nicoletta F. Jaberg-Bentele, Phil F. Cheng, Anaïs Courtier, Sabrina A. Hogan
Figure Legends for Supplemental Figures 1-4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25269a334a7acee2caf869b2771c70d3
https://doi.org/10.1158/2326-6066.22536020
https://doi.org/10.1158/2326-6066.22536020
Autor:
Mitchell P. Levesque, Reinhard Dummer, John B.A.G. Haanen, Nicolas Pasqual, Pia Kvistborg, Marieke I.G. Raaijmakers, Thi Dan Linh Nguyen-Kim, Jean-François Mouret, Nadia Plantier, Solène Perez, Manuarii Manuel, Simone M. Goldinger, Nicoletta F. Jaberg-Bentele, Phil F. Cheng, Anaïs Courtier, Sabrina A. Hogan
Many metastatic melanoma patients experience durable responses to anti-PD1 and/or anti-CTLA4; however, a significant proportion (over 50%) do not benefit from the therapies. In this study, we sought to assess pretreatment liquid biopsies for biomarke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1af8cde818efcf21e10b8eaa589b0b65
https://doi.org/10.1158/2326-6066.c.6548021.v1
https://doi.org/10.1158/2326-6066.c.6548021.v1
Autor:
Nadia Plantier, Sabrina A. Hogan, Simone M. Goldinger, Marieke I.G. Raaijmakers, Anais Courtier, Jean-François Mouret, Thi Dan Linh Nguyen-Kim, Phil F. Cheng, John B. A. G. Haanen, Mitchell P. Levesque, Solène Perez, Pia Kvistborg, Reinhard Dummer, Nicoletta F Jaberg-Bentele, Manuarii Manuel, Nicolas Pasqual
Publikováno v:
Cancer Immunology Research
Many metastatic melanoma patients experience durable responses to anti-PD1 and/or anti-CTLA4; however, a significant proportion (over 50%) do not benefit from the therapies. In this study, we sought to assess pretreatment liquid biopsies for biomarke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2183a0c56e9ee4715bc5ea53f32f0b44
https://doi.org/10.1158/2326-6066.cir-18-0136
https://doi.org/10.1158/2326-6066.cir-18-0136
Publikováno v:
Case Reports in Dermatology
Case Reports in Dermatology, Vol 9, Iss 1, Pp 65-68 (2017)
Case Reports in Dermatology, Vol 9, Iss 1, Pp 65-68 (2017)
A 47-year-old female patient with rheumatoid arthritis (RA) treated with methotrexate, was diagnosed with metastatic melanoma. After surgical removal of the tumor, the patient started treatment with ipilimumab while methotrexate was stopped. One week
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::506be2b01b0a1fff2752cb2be33d637b
https://www.zora.uzh.ch/id/eprint/136063/
https://www.zora.uzh.ch/id/eprint/136063/
Autor:
Ursula Urner-Bloch, Martin Urner, Nicoletta F Jaberg-Bentele, Anna L. Frauchiger, Simone M. Goldinger, Reinhard Dummer
Publikováno v:
European journal of cancer (Oxford, England : 1990). 65
Background Mitogen-activated protein kinase kinase (MEK) inhibitors have aroused considerable interest in oncology. Activity has been demonstrated in various types of cancer, especially melanoma. MEK inhibitors induce a transient retinopathy, conside
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3feb9dc5459aeebe0629ebcba52b4513
https://pubmed.ncbi.nlm.nih.gov/27497344
https://pubmed.ncbi.nlm.nih.gov/27497344
Autor:
Michael Kunz, Phil F. Cheng, Emmanuella Guenova, S. Thurneysen, Reinhard Dummer, Simone M. Goldinger, Mirjam Nägeli, M. Ziegler, J. Mangana, Nicoletta F Jaberg-Bentele, Hannes W. Nagel, Mitch Levesque
Publikováno v:
The British journal of dermatology. 175(5)
SummaryBackground There is a medical need for new drugs in patients with BRAF wild-type metastatic melanoma. Pazopanib is a multitarget tyrosine kinase inhibitor with antitumour and antiangiogenic activity. Objectives The primary aim was to investiga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87069b105088f39a96cedaa42343db17
https://pubmed.ncbi.nlm.nih.gov/27168024
https://pubmed.ncbi.nlm.nih.gov/27168024
Autor:
Manuarii Manuel, Thi Dan Linh Nguyen-Kim, Mitchell P. Levesque, Nicoletta F Jaberg-Bentele, Bertrand Treillard, Marieke I.G. Raaijmakers, Nadia Plantier, Pia Kvistborg, Reinhard Dummer, Anais Courtier, Sabrina Schindler, John B. A. G. Haanen, Marlene Noel, Simone M. Goldinger
Publikováno v:
Journal of Clinical Oncology. 34:3026-3026
3026Background: Anti-PD-1 and/or anti-CTLA-4 antibodies show durable responses in metastatic melanoma. Measuring the diversity of T lymphocytes in pre-treatment liquid biopsies may help stratify pa...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68d136da678a07d0528db6cf0efabd75
https://doi.org/10.1200/jco.2016.34.15_suppl.3026
https://doi.org/10.1200/jco.2016.34.15_suppl.3026